S785 Efficacy and Safety of Enhanced Endoscopic Sleeve Gastroplasty With Argon Plasma Coagulation vs Endoscopic Sleeve Gastroplasty Alone: A Systematic Review and Meta-Analysis

Introduction: Endoscopic sleeve gastroplasty (ESG), is a novel technique that reduces the gastric size reservoir using a full-thickness endoscopic suturing device. Its impact on weight loss has been significantly higher than lifestyle changes alone. There is a direct correlation between the integrity of the ESG and the achieved percentage of total body weight loss (%TBWL). Although, argon plasma coagulation (APC) is primarily used for the management of hemostasis by applying non-contact mucosal thermal ablation; its application before ESG could enhance wound healing and subsequent fibrosis, reducing suture dehiscence. Methods: Following the PRISMA guidelines, a systematic review and meta-analysis were performed to determine the impact of APC prior to ESG for weight loss. Primary outcomes were %TBWL at 6 and 12 months. Gray literature was included due to technique novelty. Data was analyzed using R version 4.2.2. The risk of bias was assessed by the Rob-2 and Robins-I tool. The quality of evidence was graded using the GRADE and Newcastle-Ottawa guidelines. Results: Two observational and one randomized clinical trial described the total weight loss at 6 and 12 months of ESG + APC vs ESG, totaling 231 patients. Meta-analysis test for overall effect showed no statistically significant difference between groups (SMD = 0.70; 95% CI = [-0.90; 2.30]; P = 0.20; and SMD = 0.77; 95% CI = [-0.57; 2.11]; P = 0.13, respectively). Similarly, there was no statistically significant difference in terms of rate of adverse events between groups (RR = 0.39; 95% CI = [0.13; 1.16]; P = 0.07). The risk of bias was moderate with moderate quality of evidence amongst the included studies. Conclusion: Our updated systematic review and meta-analysis demonstrated an absence of statistically significant difference in %TBWL loss at 6 to 12 months between ESG + APC compared to ESG alone. Further randomized studies are needed to confirm these findings.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001130600.16812.6d
Primary Topic
Bariatric Surgery and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S785 Efficacy and Safety of Enhanced Endoscopic Sleeve Gastroplasty With Argon Plasma Coagulation vs Endoscopic Sleeve Gastroplasty Alone: A Systematic Review and Meta-Analysis

Adham E Obeidat, Guadalupe Aguilar, Gulshan Parasher, Abu Baker Sheikh et al.
The American Journal of Gastroenterology
Bariatric Surgery and Outcomes
article

S785 Efficacy and Safety of Enhanced Endoscopic Sleeve Gastroplasty With Argon Plasma Coagulation vs Endoscopic Sleeve Gastroplasty Alone: A Systematic Review and Meta-Analysis

Adham E Obeidat, Guadalupe Aguilar, Gulshan Parasher, Abu Baker Sheikh, Udita Gupta, Alan Gabriel Ortega Macias, Pooja Viswanath
article en

Abstract

Introduction: Endoscopic sleeve gastroplasty (ESG), is a novel technique that reduces the gastric size reservoir using a full-thickness endoscopic suturing device. Its impact on weight loss has been significantly higher than lifestyle changes alone. There is a direct correlation between the integrity of the ESG and the achieved percentage of total body weight loss (%TBWL). Although, argon plasma coagulation (APC) is primarily used for the management of hemostasis by applying non-contact mucosal thermal ablation; its application before ESG could enhance wound healing and subsequent fibrosis, reducing suture dehiscence. Methods: Following the PRISMA guidelines, a systematic review and meta-analysis were performed to determine the impact of APC prior to ESG for weight loss. Primary outcomes were %TBWL at 6 and 12 months. Gray literature was included due to technique novelty. Data was analyzed using R version 4.2.2. The risk of bias was assessed by the Rob-2 and Robins-I tool. The quality of evidence was graded using the GRADE and Newcastle-Ottawa guidelines. Results: Two observational and one randomized clinical trial described the total weight loss at 6 and 12 months of ESG + APC vs ESG, totaling 231 patients. Meta-analysis test for overall effect showed no statistically significant difference between groups (SMD = 0.70; 95% CI = [-0.90; 2.30]; P = 0.20; and SMD = 0.77; 95% CI = [-0.57; 2.11]; P = 0.13, respectively). Similarly, there was no statistically significant difference in terms of rate of adverse events between groups (RR = 0.39; 95% CI = [0.13; 1.16]; P = 0.07). The risk of bias was moderate with moderate quality of evidence amongst the included studies. Conclusion: Our updated systematic review and meta-analysis demonstrated an absence of statistically significant difference in %TBWL loss at 6 to 12 months between ESG + APC compared to ESG alone. Further randomized studies are needed to confirm these findings.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 48%
Bariatric Surgery and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.